Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Testicular Cancer
Regimen:
TI-CE (carboplatin + etoposide IV + ifosfamide + paclitaxel)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
NCCN
Excerpt:
Testicular cancer: Second-line chemotherapy regimens for metastatic germ cell tumors…Preferred regimens (High-Dose chemotherapy)…Paclitaxel/ifosfamide/carboplatin/etoposide
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login